Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2020-06-03 2020-05-01
Drug Identification Number 02238830 02238830
Brand name CLAVULIN 400 CLAVULIN 400
Common or Proper name amoxicillin / clavulanate potassium for oral suspension amoxicillin / clavulanate potassium for oral suspension
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients CLAVULANIC ACID AMOXICILLIN CLAVULANIC ACID AMOXICILLIN
Strength(s) 57MG 400MG 57MG 400MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 70mL 70mL
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-01 2020-04-01
Estimated end date Unknown Unknown
Actual end date 2020-06-01
Shortage status Resolved Actual shortage
Company comments Re-supply is ongoing with inventory allocated to 100% of regular demand. Re-supply is ongoing with inventory allocated to 100% of regular demand.
Health Canada comments